12360327

Source:http://linkedlifedata.com/resource/pubmed/id/12360327

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002395, umls-concept:C0021083, umls-concept:C0439659, umls-concept:C0444930
pubmed:issue	10
pubmed:dateCreated	2002-10-2
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100962781
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/AN-1792, http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Vaccines
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1471-003X
pubmed:author	pubmed-author:SchenkDaleD
pubmed:issnType	Print
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	824-8
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:12360327-Alzheimer Disease, pubmed-meshheading:12360327-Amyloid beta-Peptides, pubmed-meshheading:12360327-Animals, pubmed-meshheading:12360327-Antibodies, pubmed-meshheading:12360327-Antibodies, Monoclonal, pubmed-meshheading:12360327-Clinical Trials, Phase I as Topic, pubmed-meshheading:12360327-Clinical Trials, Phase II as Topic, pubmed-meshheading:12360327-Disease Models, Animal, pubmed-meshheading:12360327-Humans, pubmed-meshheading:12360327-Immunization, Passive, pubmed-meshheading:12360327-Immunotherapy, Active, pubmed-meshheading:12360327-Meningoencephalitis, pubmed-meshheading:12360327-Mice, pubmed-meshheading:12360327-Mice, Transgenic, pubmed-meshheading:12360327-Peptide Fragments, pubmed-meshheading:12360327-Treatment Outcome, pubmed-meshheading:12360327-Vaccines
pubmed:year	2002
pubmed:articleTitle	Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
pubmed:affiliation	Elan Pharmaceuticals, 800 Gateway Boulevard, South San Francisco, California 94080, USA. dale.schenk@elan.com
pubmed:publicationType	Journal Article, Review